Company Search:
Advanced Search
Sponsored Links
Chimerix Inc Company Snapshot
Chimerix Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chimerix Inc with three other companies in this sector in the United States: ArQule, Inc. (2015 sales of $11.24 million of which 100% was Chemical Compounds), Onconova Therapeutics Inc ($11.46 million of which 100% was Identification and), and Pharmathene Inc. ($10.64 million of which 100% was Biodefence Products).

Sales Analysis. Sales increased substantially in 2015: Chimerix Inc reported sales of $10.76 million for the year ending December of 2015. This represents an increase of 166.4% versus 2014, when the company's sales were $4.04 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Chimerix Inc
  Stock Performance Chart for Chimerix Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 4.90
(Figures in U.S. Dollars)
1 Week 1.0%   13 Weeks 3.2%  
4 Weeks 7.0%   52 Weeks -45.4%  
Chimerix Inc Key Data:
  Ticker: CMRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 10,762,000
(Year Ending Jan 2016).
Employees: 131
  Currency: U.S. Dollars Market Cap: 226,945,583
  Fiscal Yr Ends: December Shares Outstanding: 46,315,425
  Share Type: Common Closely Held Shares: 946,268
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.